They found that the cut-off value of 53.5 ng/ml Gal-3 exhibited good predictive power on functional outcomes of AIS patients with an AUC of 0.884, a sensitivity of 88.4%, and a specificity of 76.9%. The gene discussed is LGALS3; the disease is androgen insensitivity syndrome.